Skip to Main Content

Author Details

Margaret Soucheray
J. David Gladstone Institutes
2012
23
16
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37738970SARS-CoV-2 variants evolve convergent strategies to remodel the host response.Cell2023
37758692Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets.Nat Commun2023
37738983Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.Cell Host Microbe2023
35332335Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2.Nature2022
36052496Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.Cancer Res2022
36052495Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.Cancer Res2022
34942634Evolution of enhanced innate immune evasion by SARS-CoV-2.Nature2022
34127972Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant.bioRxiv2021
34591612A protein interaction landscape of breast cancer.Science2021
34551310Brown adipocyte ATF4 activation improves thermoregulation and systemic metabolism.Cell Rep2021
34591642A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity.Science2021
32353859A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.Nature2020
33060197Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.Science2020
32747363Endothelin-1-Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma.Cancer Res2020
32645325The Global Phosphorylation Landscape of SARS-CoV-2 Infection.Cell2020
31273063CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC.Cancer Res2019
29440171Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.Cancer Res2018
30030465Sympathetic inputs regulate adaptive thermogenesis in brown adipose tissue through cAMP-Salt inducible kinase axis.Sci Rep2018
26833127STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment.Cancer Res2016
26282169Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition.Cancer Res2015
24045185Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.Clin Cancer Res2013
24078774Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors.Cancer Discov2013
22589302Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer.Proc Natl Acad Sci U S A2012
  • 1 - 23 of 23

Recommended Authors

University of Texas Southwestern Medical Center
Career Start Year 2017
Number of shared co-authors 1
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Career Start Year 2012
Number of shared co-authors 1
University of California san francisco
Career Start Year 2012
Number of shared co-authors 12
Stanford University School of Medicine
Career Start Year 2012
Number of shared co-authors 3
UPMC Hillman Cancer Center
Career Start Year 2012
Number of shared co-authors 2
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Career Start Year 2010
Number of shared co-authors 59
Lombardi Comprehensive Cancer Center, Georgetown University
Career Start Year 2010
Number of shared co-authors 0
Incyte Research Institute, Incyte Corporation
Career Start Year 2010
Number of shared co-authors 3
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2009
Number of shared co-authors 0
Laura and Isaac Perlmutter Cancer Center
Career Start Year 2007
Number of shared co-authors 3
Sheffield Institute of Translational Neuroscience, University of Sheffield
Career Start Year 2006
Number of shared co-authors 1
University of Cologne, Faculty of Medicine and University Hospital Cologne
Career Start Year 2005
Number of shared co-authors 8
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 7
Hadassah Ein-Kerem Medical Center Campus
Career Start Year 2004
Number of shared co-authors 7
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 1
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 1
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 7
College of Life Science, CHA University
Career Start Year 2003
Number of shared co-authors 0
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 4
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 1
University of California san francisco
Career Start Year 2002
Number of shared co-authors 15
University of California san francisco
Career Start Year 1998
Number of shared co-authors 4
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 1
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 7
Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center
Career Start Year 1994
Number of shared co-authors 2
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 2
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 6
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 4
University Health Network, University of Toronto
Career Start Year 1972
Number of shared co-authors 6

Collaborators

University of California San Francisco
Co-authored papers 16
J. David Gladstone Institutes
Co-authored papers 13
J. David Gladstone Institutes
Co-authored papers 11
J. David Gladstone Institutes
Co-authored papers 8
University of California San Francisco
Co-authored papers 8
University of California San Francisco
Co-authored papers 7
Institute of Molecular Systems Biology, ETH Zurich
Co-authored papers 7
Icahn School of Medicine at Mount Sinai
Co-authored papers 7
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 7
University of California San Francisco
Co-authored papers 6
University of California, San Francisco
Co-authored papers 6
Cardiovascular Research Institute, University of California San Francisco
Co-authored papers 6
J. David Gladstone Institutes
Co-authored papers 6
Fred Hutchinson Cancer Center
Co-authored papers 6
University of California, University of California San Francisco
Co-authored papers 6
European Bioinformatics Institute
Co-authored papers 6
University of Wisconsin-Madison
Co-authored papers 5
J. David Gladstone Institutes
Co-authored papers 5
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Zai Lab (US) LLC
Co-authored papers 4
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 4
University of California San Francisco
Co-authored papers 4
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 4
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 4
Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College
Co-authored papers 4
University of California san francisco
Co-authored papers 4
J. David Gladstone Institutes
Co-authored papers 4
University of California san francisco
Co-authored papers 4
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 4
University College London
Co-authored papers 4